The Development and Characterization of Two Monoclonal Antibodies Against the Conjugates and Derivatives of the Immunometabolite Itaconate

The Development and Characterization of Two Monoclonal Antibodies Against the Conjugates and Derivatives of the Immunometabolite Itaconate

Saved in:

Bibliographic Details
Main Authors:	Lauren Switala, Lin Di, Simona Colantonio, Bindu Lakshman, Tessa W. Caceres, Joshua J. Reading, Sandra S. Garcia-Buntley, Andrei Maiseyeu
Format:	Article
Language:	English
Published:	American Chemical Society 2024-12-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.4c08552
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Conjugation of Daunorubicin to Monoclonal Antihuman Sarcoma Antibody by a Novel Method
by: Michel Pagé, et al.
Published: (1992-01-01)

Monoclonal Antibodies Conjugated with Superparamagnetic Iron Oxide Particles Allow Magnetic Resonance Imaging Detection of Lymphocytes in the Mouse Brain
by: Alessandro Luchetti, et al.
Published: (2012-03-01)

Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2024-10-01)

Role of Monoclonal Antibodies in the Treatment of Asthma
by: Paul M O’Byrne
Published: (2013-01-01)

Corrigendum: Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2025-02-01)

How to use monoclonal antibody-based therapy in ALL
by: Erica Brivio, et al.
Published: (2025-06-01)

Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM)
by: Rethinam Senthil, et al.
Published: (2024-03-01)

Monoclonal Antibodies in Prevention and Early Treatment of COVID-19 in Lung Transplant Recipients: A Systematic Review and Perspective on the Role of Monoclonal Antibodies in the Future
by: David A. Van Eijndhoven, et al.
Published: (2025-02-01)

New Antibody Conjugates in Cancer Therapy
by: Serengulam V. Govindan, et al.
Published: (2010-01-01)

The cell autonomous and non-autonomous roles of itaconate in immune response
by: Chao Chen, et al.
Published: (2025-02-01)

Reduction of monoclonal antibody viscosity using interpretable machine learning
by: Emily K. Makowski, et al.
Published: (2024-12-01)

D8/17 Monoclonal Antibody: An Unclear Neuropsychiatric Marker
by: Astrid Morer, et al.
Published: (2005-01-01)

Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives
by: Giulia Motta, et al.
Published: (2010-01-01)

Methodological validation study of nrCE-SDS for monoclonal antibodies
by: Xu Gangling, et al.
Published: (2024-12-01)

Sustainable Downstream Separation of Itaconic Acid Using Carbon-Based Adsorbents
by: Alejandra Ortíz-de-Lira, et al.
Published: (2022-01-01)

Current issues with antibody-conjugated lipid nanoparticles
by: Aayush
Published: (2025-02-01)

Assessment of targets of antibody drug conjugates in SCLC
by: Abhishek Ajay, et al.
Published: (2025-01-01)

Preliminary Characterization of a Monoclonal Antibody (AS-2) against Cell Cycle Related Proteins
by: Stefano Nigro, et al.
Published: (1998-01-01)

Predicting purification process fit of monoclonal antibodies using machine learning
by: Andrew Maier, et al.
Published: (2025-12-01)

Monoclonal Antibodies for Treatment of COVID-19: An Updated Review of Current Evidence
by: Saurabh Nimesh, et al.
Published: (2024-11-01)

Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era
by: Serena Vita, et al.
Published: (2024-04-01)

Synthesis, Characterization and In Vitro Anticancer Evaluation of Itaconic Acid Based Random Copolyester
by: J. Gowsika, et al.
Published: (2014-01-01)

Hepatoprotective Role of 4-Octyl Itaconate in Concanavalin A-Induced Autoimmune Hepatitis
by: Wenchang Yang, et al.
Published: (2022-01-01)

Clinical advances in antibody-drug conjugates for hematological malignancies
by: TANG Sijie, et al.
Published: (2024-12-01)

The history and potential future of monoclonal antibody therapeutics development and manufacturing in four eras
by: Brian Kelley
Published: (2024-12-01)

A tailored lectin microarray for rapid glycan profiling of therapeutic monoclonal antibodies
by: Shen Luo, et al.
Published: (2024-12-01)

Characterization of two neutralizing monoclonal antibodies with conformational epitopes against porcine deltacoronavirus
by: Wan Lu, et al.
Published: (2025-01-01)

Spatiotemporal regulation of alginate sub-structures at multiple scales revealed by monoclonal antibodies
by: Catherine T. Jones, et al.
Published: (2025-06-01)

Tocilizumab-induced anaphylactic reactions in rheumatic diseases: Consideration for clinicians with monoclonal antibody infusions
by: Amee D Pandya, et al.
Published: (2019-01-01)

A Quantitative Method for Detecting Ara h 2 by Generation and Utilization of Monoclonal Antibodies
by: Huifang Chen, et al.
Published: (2018-01-01)

A Simple Methodology for Conversion of Mouse Monoclonal Antibody to Human-Mouse Chimeric Form
by: Vinh T. Dang, et al.
Published: (2013-01-01)

Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy
by: Vito Pistoia, et al.
Published: (2016-01-01)

Understanding the impacts of dual methionine oxidations in complementarity-determining regions on the structure of monoclonal antibodies
by: Bo Zhao, et al.
Published: (2024-12-01)

Preparation and application evaluation of monoclonal antibodies against Monkeypox virus A29 protein
by: Ai Xiangjun, et al.
Published: (2025-01-01)

Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus
by: Yanfang Zhang, et al.
Published: (2025-01-01)

Monoclonal antibody development and antigenic epitope identification of chicken pro-IL-1β
by: Mengmeng Xu, et al.
Published: (2025-02-01)

4-Octyl itaconate inhibits synovitis in the mouse model of post-traumatic osteoarthritis and alleviates pain
by: Yu-Zhen Tang, et al.
Published: (2025-01-01)

Development of a stable eukaryotic strain producing fully human monoclonal antibody on the basis of the human antibody against ectromelia virus
by: A. L. Matveev, et al.
Published: (2018-01-01)

Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates
by: Yangyang Gao, et al.
Published: (2025-01-01)

Comparative Analysis of Nanoparticle-Antibody Conjugations: Carbodiimide Versus Click Chemistry
by: Daniel L.J. Thorek, et al.
Published: (2009-07-01)